-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Cognition Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2024.
- Cognition Therapeutics Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$7.24M, a 168% decline year-over-year.
- Cognition Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$16M, a 13.6% increase from 2022.
- Cognition Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$18.5M, a 410% decline from 2021.
- Cognition Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$3.63M, a 5.77% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)